Issuance of ¥8,000 million in Convertible Bonds with Stock Acquisition Rights
First written in FY2019-Q1. 3 of 7 entries say "Achieved", first in FY2019. Latest entry: FY2025.
21 other companies' latest entry also says "Achieved".
- FY2025AchievedAnnual report
「The company recorded ¥1,638 million in extraordinary income, primarily from gains on the reversal of stock acquisition rights, in connection with the redemption of euro-yen convertible bonds with stock acquisition rights due 2025.」
Redemption of the euro-yen convertible bonds with stock acquisition rights due 2025 was completed, and the company recorded a ¥1,632 million gain on the reversal of the related stock acquisition rights. - FY2023RestatedAnnual report
「On 29 January 2021, the company issued euro-yen convertible bonds with stock acquisition rights due 2025, with a total face value of ¥23 billion.」
The company continues to disclose the ¥22,936 million balance of convertible bonds with stock acquisition rights due January 2025, as well as the redemption and refinancing risks. - FY2022RestatedAnnual report
「On 29 January 2021, the company issued euro-yen convertible bonds with stock acquisition rights due 2025, with a total face value of ¥23 billion.」
¥22,902 million of convertible bonds due 2025 remains outstanding, and the company continues to disclose the issued debt and its conversion and redemption terms. - FY2020-Q3AchievedAnnual report
「For the second series of unsecured convertible bonds with stock acquisition rights, with a face value of ¥4 billion, requests to exercise the stock acquisition rights were made for the entire amount by 29 January 2020, as stated under significant subsequent events, and conversion into common shares was completed.」
Exercise of the stock acquisition rights and conversion into common shares for the entire ¥4 billion face value of the second series of convertible bonds were completed by 29 January 2020. Together with the first series, conversion of the entire ¥8 billion issued has been completed. - FY2020-Q2Conversion completed for the first series of convertible bondsAnnual report
「On 7 June 2018, the company issued the first and second series of unsecured convertible bonds with stock acquisition rights, with a total face value of ¥8 billion. Requests to exercise the stock acquisition rights were made for the entire ¥4 billion face value of the first series, and conversion into common shares has been completed.」
Of the ¥8 billion of convertible bonds issued, requests to exercise the stock acquisition rights were made for the entire ¥4 billion first series, and conversion into common shares was completed. - FY2019AchievedAnnual report
「During the fiscal year, the company raised ¥8,000 million through the issuance of convertible bonds with stock acquisition rights to expand the floor space of its contact lens manufacturing plant and add contact lens production lines.」
The company issued the first and second series of convertible bonds with stock acquisition rights and raised a total of ¥8,000 million. The stated uses of the proceeds were to expand factory floor space and add production lines. - FY2019-Q1First statedAnnual report
「The bonds with stock acquisition rights issued during the first quarter are as follows.」
On 7 June 2018, the company issued ¥4,000 million each of the first and second series of unsecured convertible bonds with stock acquisition rights, for a total of ¥8,000 million. The conversion prices were ¥3,219 and ¥3,525, respectively, and the exercise period was from 14 June 2018 through 25 May 2021.